Matches in Wikidata for { <http://www.wikidata.org/entity/Q76983252> ?p ?o ?g. }
Showing items 1 to 38 of
38
with 100 items per page.
- Q76983252 description "clinical trial" @default.
- Q76983252 description "ensayu clínicu" @default.
- Q76983252 description "klinisch onderzoek" @default.
- Q76983252 description "клінічне випробування" @default.
- Q76983252 description "կլինիկական փորձարկում" @default.
- Q76983252 name "SARC037: A Phase I Study to Evaluate the Safety of Trabectedin in Combination With Irinotecan in Ewing Sarcoma Patients" @default.
- Q76983252 name "SARC037: A Phase I Study to Evaluate the Safety of Trabectedin in Combination With Irinotecan in Ewing Sarcoma Patients" @default.
- Q76983252 type Item @default.
- Q76983252 label "SARC037: A Phase I Study to Evaluate the Safety of Trabectedin in Combination With Irinotecan in Ewing Sarcoma Patients" @default.
- Q76983252 label "SARC037: A Phase I Study to Evaluate the Safety of Trabectedin in Combination With Irinotecan in Ewing Sarcoma Patients" @default.
- Q76983252 prefLabel "SARC037: A Phase I Study to Evaluate the Safety of Trabectedin in Combination With Irinotecan in Ewing Sarcoma Patients" @default.
- Q76983252 prefLabel "SARC037: A Phase I Study to Evaluate the Safety of Trabectedin in Combination With Irinotecan in Ewing Sarcoma Patients" @default.
- Q76983252 P1050 Q76983252-B52B0A43-E3D8-47E6-8B5C-D3BF013C1572 @default.
- Q76983252 P1132 Q76983252-90239232-CD7A-4AA8-B55A-F2A01790DF45 @default.
- Q76983252 P1476 Q76983252-827CA9F2-2F66-4843-B0E4-040B4ADF3412 @default.
- Q76983252 P1813 Q76983252-CAD4C743-BE9B-4366-A395-DD4CC7940DE6 @default.
- Q76983252 P2899 Q76983252-18631EB9-9FFF-48AA-BE5A-B2118D896D42 @default.
- Q76983252 P3098 Q76983252-DD2E325B-1ABD-47F4-8493-203B7CA30823 @default.
- Q76983252 P31 Q76983252-FE1D4590-1FF0-456B-9B8D-FD6478A4A3B7 @default.
- Q76983252 P4844 Q76983252-85176932-ACF6-4F3A-A353-805C3C07597A @default.
- Q76983252 P580 Q76983252-38BF42AE-093B-4C04-A906-3F089173F34C @default.
- Q76983252 P582 Q76983252-0EA001F4-FD9E-46EF-8C35-48834D440695 @default.
- Q76983252 P6099 Q76983252-7BDF0BEA-AACD-49A4-A97D-9B3504B55B99 @default.
- Q76983252 P8363 Q76983252-2382C532-7D8B-4886-BC0E-1CB0CB436713 @default.
- Q76983252 P859 Q76983252-2725B126-C6FA-4265-A4D9-167B2E03E554 @default.
- Q76983252 P1050 Q223911 @default.
- Q76983252 P1132 "+45" @default.
- Q76983252 P1476 "SARC037: A Phase I Study to Evaluate the Safety of Trabectedin Administered as a 1-Hour Infusion in Ewing Sarcoma Patients in Combination With Low Dose Irinotecan and 3'-Deoxy-3'-18F Fluorothymidine (18F-FLT) Imaging" @default.
- Q76983252 P1813 "U01CA236220" @default.
- Q76983252 P2899 "+10" @default.
- Q76983252 P3098 "NCT04067115" @default.
- Q76983252 P31 Q30612 @default.
- Q76983252 P4844 Q412197 @default.
- Q76983252 P580 "2019-10-01T00:00:00Z" @default.
- Q76983252 P582 "2023-07-01T00:00:00Z" @default.
- Q76983252 P6099 Q5452194 @default.
- Q76983252 P8363 Q78089383 @default.
- Q76983252 P859 Q61930710 @default.